Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jul;6(7):1-16.

The Treatment of Patients With Hepatic Encephalopathy: Review of the Latest Data from EASL 2010

Kevin D Mullen  1
Affiliations

The Treatment of Patients With Hepatic Encephalopathy: Review of the Latest Data from EASL 2010

Kevin D Mullen. Gastroenterol Hepatol (N Y). 2010 Jul.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Disclosure of Conflicts of Interest:Postgraduate Institute for Medicine (PIM) assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by PIM for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. PIM is committed to providing its learners with high-quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Disclosures

Kevin D. Mullen, MD—consulting fees: Salix Pharmaceuticals; fees for nonCME services: Hoffman-La Roche.

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

The following PIM planners and managers, Jan Hixon, RN, BSN, MA, Trace Hutchison, PharmD, Julia Kirkwood, RN, BSN, Samantha Mattiucci, PharmD, Jan Schultz, RN, MSN, CCMEP, and Patricia Staples, MSN, NP-C, CCRN, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Figures

Figure 1
Figure 1
Global cognitive function.
Figure 2
Figure 2
MRI measurement of brain volume.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

  • Hepatic encephalopathy.
    Bleibel W, Al-Osaimi AM. Bleibel W, et al. Saudi J Gastroenterol. 2012 Sep-Oct;18(5):301-9. doi: 10.4103/1319-3767.101123. Saudi J Gastroenterol. 2012. PMID: 23006457 Free PMC article. Review.

References

    1. Sanyal A, Bass N, Mullen K, et al. Rifaximin treatment improved quality of life in patients with hepatic encephalopathy: results of a large, randomized, placebo-controlled trial. Program and abstracts of the 45th Annual Meeting of the European Association for the Study of the Liver; April 14-18, 2010; Vienna, Austria 2010; Abstract 15.
    1. Bass NM, Mullen KD, Sanyal A, et al. Rifaximin treatment in hepatic encephalopathy. N Engl J Med. 2010;362:1071–1081. - PubMed
    1. Bajaj J, Heuman DM, Schubert C, et al. Persistent deficity in learning of response inhibition following onset of overt hepatic encephalopathy in cirrhosis. Program and abstracts of the 45th Annual Meeting of the European Association for the Study of the Liver; April 14-18, 2010; Vienna, Austria 2010; Abstract 149.
    1. Bajaj J, Schubert C, Sanyal AJ, Bell D, Pisney L, Heuman DM. Severity of chronic cognitive impairment in cirrhosis increases with number of episodes of overt hepatic encephalopathy. Program and abstracts of the 45th Annual Meeting of the European Association for the Study of the Liver; April 14-18, 2010; Vienna, Austria 2010; Abstract 150.
    1. Diaz-Herrero MM, del Campo JA, Carbonero P, et al. THDP-17 inhibits the glutaminase activity in Caco-2 cell cultures. Program and abstracts of the 45th Annual Meeting of the European Association for the Study of the Liver; April 14-18, 2010; Vienna, Austria 2010; Abstract 161.

LinkOut - more resources